Indegene
1 Case Studies
A Indegene Case Study
A leading global top-5 pharmaceutical company in oncology partnered with Indegene to understand the complex drivers behind patients switching away from its novel androgen deprivation therapy (ADT). While adoption was strong, the company lacked insight into why unexplained switching was occurring early in treatment, as its data was siloed and existing analyses only provided surface-level metrics without actionable insights.
Indegene implemented a solution combining patient journey analysis with machine learning using real-world data. Their approach integrated medical and non-medical signals to build a Random Forest model that identified key switch drivers, such as treatment gaps and payer channel. This enabled patient-level risk scoring and proactive intervention planning. The analysis revealed that 53% of patients under commercial payers switched therapies, and Indegene's GenAI-powered interface allowed stakeholders to query the data for actionable recommendations.
Leading Global Top-5 Pharmaceutical Company in Oncology